| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.67B | 32.54B | 29.26B | 29.85B | 25.32B | 19.33B |
| Gross Profit | 10.86B | 8.31B | 5.54B | 12.17B | 9.60B | 8.47B |
| EBITDA | 2.38B | 2.19B | 2.94B | 2.37B | 1.73B | 2.35B |
| Net Income | 276.10M | 206.10M | 1.08B | 779.90M | 434.70M | 739.20M |
Balance Sheet | ||||||
| Total Assets | 29.24B | 29.80B | 26.97B | 24.56B | 23.59B | 16.22B |
| Cash, Cash Equivalents and Short-Term Investments | 380.30M | 147.90M | 167.20M | 310.90M | 88.10M | 59.60M |
| Total Debt | 7.95B | 8.86B | 8.42B | 6.62B | 6.10B | 2.08B |
| Total Liabilities | 17.70B | 17.96B | 15.85B | 14.22B | 13.89B | 7.98B |
| Stockholders Equity | 11.54B | 11.84B | 11.12B | 10.34B | 9.71B | 8.25B |
Cash Flow | ||||||
| Free Cash Flow | 1.35B | -107.10M | -228.50M | -18.00M | -3.47B | 2.10B |
| Operating Cash Flow | 2.06B | 1.50B | 2.28B | 2.06B | -621.40M | 3.07B |
| Investing Cash Flow | -667.90M | -1.60B | -3.27B | -2.02B | -2.82B | -918.50M |
| Financing Cash Flow | -1.31B | 63.40M | 1.01B | 2.70M | 3.48B | -2.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ₹12.65B | 13.53 | ― | 0.95% | -1.59% | -75.34% | |
63 Neutral | ₹15.94B | 32.60 | ― | 0.33% | 13.68% | 33.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | ₹20.57B | 80.19 | ― | 0.46% | 7.37% | -39.19% | |
53 Neutral | ₹26.83B | 72.23 | ― | 0.40% | 8.03% | -57.44% | |
43 Neutral | ₹10.55B | 46.69 | ― | 0.21% | -7.55% | -30.11% | |
40 Underperform | ₹11.29B | 52.64 | ― | ― | 22.75% | ― |